- Report
- April 2025
- 100 Pages
Global
From €5219EUR$5,950USD£4,479GBP
- Report
- May 2025
- 186 Pages
Global
From €3109EUR$3,545USD£2,669GBP
€3455EUR$3,939USD£2,965GBP
- Report
- May 2025
- 185 Pages
Global
From €3109EUR$3,545USD£2,669GBP
€3455EUR$3,939USD£2,965GBP
- Report
- May 2025
- 175 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- April 2025
- 175 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- April 2025
- 175 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- April 2025
- 175 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- April 2025
- 175 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- March 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- March 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- March 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- March 2025
- 175 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- March 2025
- 250 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- February 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- February 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- February 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- February 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- February 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- February 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- July 2024
- 303 Pages
Global
From €4385EUR$5,000USD£3,764GBP

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development.
BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more